WFNMB2022/JSNM2022/JSNMT2022

Presentation information

Print

[WFNMB]Poster

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » [WFNMB]Poster Program

Nuclear Medicine Innovation1

Therapy

Sun. Sep 11, 2022 8:00 AM - 8:00 PM Web distribution only (配信のみ)

[WP-28-8] Development of α-methylated 3-boronophenylalanine derivatives with improved LAT1/LAT2 selectivity for BNCT.

Fuko Hirano1、Naoya Kondo1、Yusuke Murata2、Aya Sudani2、Takashi Temma1 (1.Osaka Medical and Pharmaceutical University、2.Stella Pharma Corporation Sakai R&D Center)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

Password